Searchable abstracts of presentations at key conferences in endocrinology

ea0090p208 | Thyroid | ECE2023

Novel Thyroid Hormone Receptor-β Agonist TG68: a polypharmacological approach for the treatment of obesity-associated diseases

Ricardi Caterina , Polini Beatrice , Dettori Cristina , Saponaro Federica , Chiellini Grazia

Obesity is a multifactorial disease in which environmental conditions and genetic factors play an important pathogenic role [1]. Interestingly, some of these obesogenic environmental and genetic conditions are shared with neurodegenerative diseases (NDD). The common biological mechanisms involved in obesity and NDD are insulin resistance, pro-inflammatory cytokines, and oxidative damage, in turn leading to cognitive dysfunction or cell death. In this aspect, a poly-pharmacolog...

ea0084ps2-09-78 | Thyroid Hormone ACTION | ETA2022

Synthetic analogs of 3-iodothyronamine (T1AM) prevent β-amyloid neurotoxicity in an in vitro model of alzheimer’s disease (AD)

Polini Beatrice , Ricardi Caterina , Carnicelli Vittoria , Tosi Paolo , Bacci Andrea , Rapposelli Simona , Zucchi Riccardo , Chiellini Grazia

We have already reported that synthetic analogs of 3-iodothyronamine (T1AM), a naturally occurring thyroid hormone derivative, share a pleiotropic activity with the endogenous parent compound, including autophagic flux promotion (ATG), neuroprotection, and metabolic reprogramming. Our study aimed to determine whether the T1AM lead analog SG2 and its derivatives SG22 and SG23, developed as prodrugs of SG2, can protect human glioblastoma U87 MG cells from the toxic effects induc...

ea0092ps2-19-03 | Thyroid Hormone Transport & Metabolism Basic | ETA2023

Thyroid hormone metabolite 3-iodothyronamine (T1AM) as an effective repressor of microglia-mediated neuroinflammation

Polini Beatrice , Ricardi Caterina , Carnicelli Vittoria , Rutigliano Grazia , Saponaro Federica , Zucchi Riccardo , Chiellini Grazia

Microglial dysfunction is one of the hallmarks and leading causes of common neurodegenerative diseases (NDD), including Alzheimer’s disease (AD), Parkinson’s disease (AD), and amyotrophic lateral sclerosis (ALS). All these pathologies are characterized by aberrant aggregation of disease-causing proteins in the brain, which can directly activate microglia, trigger microglia-mediated neuroinflammation, and increase oxidative stress. The availability of cell-permeable i...

ea0101op-01-03 | Oral Session 1: Topic Highlights | ETA2024

Novel Tr-β selective agonist TG68 promotes anti-inflammatory, lipid-lowering and anxiolytic effects

Polini Beatrice , Ricardi Caterina , Di Lupo Francesca , Dettori Cristina , Rapposelli Simona , Saponaro Federica , Chiellini Grazia

Recent advances in drug discovery and development allowed the identification of THRβ-selective thyromimetic TG68 as a powerful lipid lowering and anti-amyloid agent. To expand our knowledge on the therapeutic potential of this novel thyromimetic, we investigated its anti-inflammatory effects in in vitro human models of neuroinflammation. Subsequently, we performed in vivo studies on high fat diet (HFD) obese/insulin resistant mice, a well-established mod...

ea0084ps2-09-85 | Thyroid Hormone ACTION | ETA2022

3-Iodothyroacetic acid release in a mouse model of ischemia-induced synaptic dysfunction

Ricardi Caterina , Bertolini Andrea , Tozzi Francesca , Polini Beatrice , Rutigliano Grazia , Zucchi Riccardo , Chiellini Grazia , Saba Alessandro , Origlia Nicola

The endogenous thyroid hormone derivative 3-iodothyronamine (T1AM), and its metabolite 3-iodothyroacetic acid (TA1) are known to stimulate learning and induce hyperalgesia in mice. Recently, it has been demonstrated that exogenous T1AM is able to rescue synaptic impairment after transient ischemia in the entorhinal cortex (EC), a brain area crucially involved in learning and memory, and early affected during Alzheimer’s disease. However, i...

ea0099rc2.2 | Rapid Communications 2: Calcium and Bone | Part I | ECE2024

Irisin levels are correlated with age and behavioural performance in Post-surgical HypoPT condition

Saponaro Federica , Chiellini Grazia , Polini Beatrice , Ricardi Caterina , Pignataro Patrizia , Zerlotin Roberta , Oranger Angela , Colucci Silvia , Di Carlo Manuela , Colaianni Graziana , Saba Alessandro , Grano Maria

Introduction: Hypoparathyroidism (HypoPT) is a rare endocrine disease and Post-surgical HypoPT (PS-HypoPT) is the most common cause, caused by accidental parathyroid injury. From a neuropsychological standpoint, patients with PS-HypoPT present cognitive and neuropsychological symptoms. Irisin is a myokine secreted by contracting muscle, which mediates beneficial effects on several targets, including brain. The aim of this study was to evaluate irisin in the context of PS-HypoP...

ea0099ep638 | Calcium and Bone | ECE2024

Evaluation of Irisin levels in a group of young patients with Cerebral Palsy compared with healthy matched controls

Saponaro Federica , Sgandurra Giuseppina , Beani Elena , Paolicelli Paola , Brunori Elena , Tinelli Francesca , Filogna Silvia , Cioni Giovanni , Chiellini Grazia , Polini Beatrice , Ricardi Caterina , Pignataro Patrizia , Colucci Silvia , Dicarlo Manuela , Zerlotin Roberta , Colaianni Graziana , Comberiati Pasquale , Baroncelli Gianpiero , Gamborino Agnese , Saba Alessandro , Grano Maria

Introduction: Cerebral palsy (CP) is the most common chronic disability in childhood, burden by motor, sensation, cognition, feeding and communication impairment. A serious concern in children with CP is bone/muscle health deterioration, which negatively impacts the already reduced quality of life (QoL). Irisin is a myokine secreted by contracting muscle, which mediates beneficial effects on several targets, including brain. The aim of this pilot study was to evaluate serum le...